SGMT - Sagimet Biosciences Series A Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SGMT is currently covered by 2 analysts with an average price target of $23.11. This is a potential upside of $15.71 (212.3%) from yesterday's end of day stock price of $7.4.

Sagimet Biosciences Series A Common Stock's activity chart (see below) currently has 0 price targets and 11 ratings on display. The stock rating distribution of SGMT is 90.91% BUY and 9.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 64 days.

Highest price target for SGMT is $6, Lowest price target is $6, average price target is $6.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 15-Aug-2024. First documented stock forecast 08-Aug-2023.

Best performing analysts who are covering SGMT - Sagimet Biosciences Series A Common Stock:

Jonathan Wolleben Andrea Tan

Currently out of the existing stock ratings of SGMT, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10 months 1 days ago
(15-Aug-2024)

0/2 (0%)

$28.58 (155.16%)

Hold

$6

$-2.27 (-27.45%)

$23

11 months 15 days ago
(01-Jul-2024)

1/4 (25%)

$2.84 (89.87%)

128

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SGMT (Sagimet Biosciences Series A Common Stock) average time for price targets to be met?

On average it took 64 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on SGMT (Sagimet Biosciences Series A Common Stock) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the current lower performing score on SGMT (Sagimet Biosciences Series A Common Stock) with a proven track record?

ANDREA TAN

Which analyst has the most public recommendations on SGMT (Sagimet Biosciences Series A Common Stock)?

Jonathan Wolleben works at JMP and has 10 price targets and 8 ratings on SGMT

Which analyst is the currently most bullish on SGMT (Sagimet Biosciences Series A Common Stock)?

Jonathan Wolleben with highest potential upside - $0

Which analyst is the currently most reserved on SGMT (Sagimet Biosciences Series A Common Stock)?

Andrea Tan with lowest potential downside - -$2.27

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?